Groupama Asset Managment
- SEC CIK
- 0001055969
- Latest filing
- Aug 14, 2026
DNLI holding history
Denali Therapeutics Inc. in every 13F filed by Groupama Asset Managment, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DNLI overviewAll 13F holders of DNLIFull Q2 2026 holdings
- Shares (Q2 2026)
- 229,939
- Value
- $5.91M
- % of portfolio
- 0.1%
- Quarters held
- 11
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 229,939 | $5.91M | 0.1% | +22,809+11.0% | Added | Holders |
| Q1 2026 | 207,130 | $3.98M | 0.1% | +55,539+36.6% | Added | Holders |
| Q4 2025 | 151,591 | $2.50M | <0.1% | +15,833+11.7% | Added | Holders |
| Q3 2025 | 135,758 | $1.97M | <0.1% | −39,773−22.7% | Reduced | Holders |
| Q2 2025 | 175,531 | $2.47M | <0.1% | +31,043+21.5% | Added | Holders |
| Q1 2025 | 144,488 | $2.14M | <0.1% | +34,281+31.1% | Added | Holders |
| Q4 2024 | 110,207 | $2.23M | <0.1% | +32,162+41.2% | Added | Holders |
| Q3 2024 | 78,045 | $1.83M | <0.1% | +5,657+7.8% | Added | Holders |
| Q2 2024 | 72,388 | $1.68M | <0.1% | +28,561+65.2% | Added | Holders |
| Q1 2024 | 43,827 | $899.3K | <0.1% | +8,814+25.2% | Added | Holders |
| Q4 2023 | 35,013 | $751.6K | <0.1% | – | No prior filing | Holders |